E-medical diagnosis support system for non-invasive liver fibrosis recognition
暂无分享,去创建一个
Bartosz Krawczyk | Tomasz Orczyk | Michal Wozniak | Joanna Musialik | Barbara Blonska-Fajfrowska | Piotr Porwik | B. Krawczyk | B. Błońska-Fajfrowska | J. Musialik | P. Porwik | T. Orczyk | M. Woźniak
[1] Piotr Porwik,et al. Adaptive Splitting and Selection Method for Noninvasive Recognition of Liver Fibrosis Stage , 2013, ACIIDS.
[2] R. Soloway,et al. APRI: An Easy and Validated Predictor of Hepatic Fibrosis in Chronic Hepatitis C , 2006, Journal of Clinical Gastroenterology.
[3] Piotr Porwik,et al. CLASSIFICATION TECHNIQUES FOR NON-INVASIVE RECOGNITION OF LIVER FIBROSIS STAGE , 2012 .
[4] I. Guha,et al. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. , 2008, Clinics in liver disease.
[5] S. Friedman,et al. Molecular regulation of hepatic fibrogenesis. , 1998, Journal of hepatology.
[6] G. Ramadori,et al. Fibrosis and Altered Matrix Synthesis , 1998, Digestion.
[7] Bogdan Wojtyniak,et al. Sytuacja zdrowotna ludności Polski i jej uwarunkowania , 2013 .
[8] Dominique Thabut,et al. Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard. , 2013, Journal of hepatology.
[9] D. Schuppan,et al. Matrix as a modulator of hepatic fibrogenesis. , 2001, Seminars in liver disease.
[10] Mion,et al. [13C]‐Galactose breath test: correlation with liver fibrosis in chronic hepatitis C , 1999, European journal of clinical investigation.
[11] R Luo,et al. [Diagnostic value of five serum markers for liver fibrosis]. , 2001, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[12] H Nishitani,et al. Chronic liver disease: value of volumetry of liver and spleen with computed tomography. , 1990, Radiation medicine.
[13] Neil Kaplowitz,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.
[14] K. Ishak,et al. Histological grading and staging of chronic hepatitis. , 1995 .
[15] E. Schiff,et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.
[16] Chia-Yen Dai,et al. The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies , 2007, Gut.
[17] J. Marín-Gabriel,et al. Noninvasive assessment of liver fibrosis. Serum markers and transient elastography (FibroScan). , 2009, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[18] Mircea Grigorescu,et al. Noninvasive biochemical markers of liver fibrosis. , 2006, Journal of gastrointestinal and liver diseases : JGLD.
[19] Lin Dai,et al. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B]. , 2003, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[20] Bartosz Krawczyk,et al. Neural Network Ensemble Based on Feature Selection for Non-Invasive Recognition of Liver Fibrosis Stage , 2014 .
[21] Herrine,et al. Schiff's diseases of the liver , 1999, Gastroenterology.
[22] M. Fried,et al. 13C‐methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry , 2007, Alimentary pharmacology & therapeutics.
[23] Piotr Porwik,et al. Cost Sensitive Hierarchical Classifiers for Non-invasive Recognition of Liver Fibrosis Stage , 2013, CORES.